Sensus Healthcare Reports First Quarter 2026 Financial Results
Sensus Healthcare, Inc. announced its financial results for Q1 2026, reporting a revenue of $3.4 million, a decrease from $8.3 million in Q1 2025. The report highlights the impact of reduced sales, particularly to its historically largest customer.
BOCA RATON, Fla.–(BUSINESS WIRE)–Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights included: Revenue of $3.4 million compared to $8.3 million for the three months ended March 31, 2025. Excluding sales to the Company’s historically largest customer, rev